Laurence Rodriguez
Directeur Général chez GENSIGHT BIOLOGICS S.A.
Postes actifs de Laurence Rodriguez
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| GENSIGHT BIOLOGICS S.A. | Directeur/Membre du Conseil | 16/01/2024 | - |
| Directeur Général | 21/12/2023 | - | |
| Directeur des opérations | 19/05/2021 | 21/12/2023 |
Historique de carrière de Laurence Rodriguez
Anciens postes connus de Laurence Rodriguez
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - | - |
Formation de Laurence Rodriguez
| Sciences Po | Graduate Degree |
Statistiques
Internationale
| France | 3 |
| Royaume-Uni | 2 |
Opérationnelle
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Chief Operating Officer | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GENSIGHT BIOLOGICS S.A. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Laurence Rodriguez
- Expérience
